(Q68628995)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

title

Involvement of thromboxane and neutrophils in multiple-system organ edema with interleukin-2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

author name string

R Welbourn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

G Goldman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

L Kobzik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

C R Valeri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

D Shepro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

H B Hechtman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

language of work or name

English

0 references

publication date

1 December 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

volume

212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

page(s)

728-733

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.

26 September 2019

cites work

1 reference

12 December 2020

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta

1 reference

12 December 2020

Monokine-induced acute lung injury in rabbits

1 reference

12 December 2020

Interleukin-2 initiates metabolic responses associated with critical illness in humans

1 reference

12 December 2020

Toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphocytes. Separation of efficacy and toxicity by selective lymphocyte subset depletion

1 reference

12 December 2020

Limb ischemia-induced increase in permeability is mediated by leukocytes and leukotrienes

1 reference

12 December 2020

IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cells

1 reference

12 December 2020

The rapid induction by interleukin-2 of pulmonary microvascular permeability

1 reference

12 December 2020

Cytokine gene expression during the generation of human lymphokine-activated killer cells: early induction of interleukin 1 beta by interleukin 2.

1 reference

12 December 2020

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

1 reference

12 December 2020

Tumor necrosis factor as an activator of human granulocytes. Potentiation of the metabolisms triggered by the Ca2+-mobilizing agonists.

1 reference

12 December 2020

IL-2 induces pulmonary edema and vasoconstriction independent of circulating lymphocytes.

1 reference

12 December 2020

Toxicity of human recombinant interleukin-2 in rats. Pathologic changes are characterized by marked lymphocytic and eosinophilic proliferation and multisystem involvement

1 reference

12 December 2020

Thromboxane A2 mediates increased pulmonary microvascular permeability following limb ischemia

1 reference

12 December 2020

Role of thromboxane in interleukin 2-induced lung injury in sheep

1 reference

12 December 2020

Thromboxane mediates the ischemia-induced neutrophil oxidative burst

1 reference

12 December 2020

Effects of interleukin-2 on pulmonary and systemic transvascular fluid filtration.

1 reference

12 December 2020

In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation

1 reference

12 December 2020

Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

The use of immobilized ligands and [125I]protein a for immunoassays of thromboxane B2, prostaglandin D2, 13,14-dihydro-prostaglandin E2, 5,6-dihydro-prostaglandin I2, 6-keto-prostaglandin F1 alpha, 15-hydroxy-9 alpha, 11 alpha(epoxymethano)prosta-5,

1 reference

12 December 2020

Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia

1 reference

12 December 2020

Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog

1 reference

12 December 2020

Leukocyte-endothelial interactions

1 reference

12 December 2020

Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth

1 reference

12 December 2020

Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta

1 reference

12 December 2020

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

1 reference

12 December 2020

Toxicity of recombinant human interleukin-2 in rats following intravenous infusion

1 reference

12 December 2020

Eicosanoid modulation of stress fibers in cultured bovine aortic endothelial cells

1 reference

12 December 2020

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2

1 reference

12 December 2020

Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon

1 reference

12 December 2020

Clinical effects and toxicity of interleukin-2 in patients with cancer

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Interleukin-1-induced granulocytopenia and pulmonary leukostasis in rabbits

1 reference

12 December 2020

Neutrophil-mediated vascular injury

1 reference

12 December 2020

10.1097/00000658-199012000-00012

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2256765%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

0 references

1 reference